Viridian Therapeutics, Inc. Common Stock (VRDN)
PHARMACEUTICAL PREPARATIONS
Viridian Therapeutics, Inc. Common Stock (VRDN) is listed on Nasdaq, where it has traded since June 18, 2014.
- Listed On
- Nasdaq
- Listed Since
- June 18, 2014
- Employees
- 252
- Market Cap
- $2.7B
About Viridian Therapeutics, Inc. Common Stock
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 207 institutions reported holding VRDN, with 135.8 million shares worth $2.5 billion in aggregate. The largest reported holder was FMR, with 16.6 million shares worth $305.0 million. Of the 5 largest holders listed below, all 5 added shares during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| FMR | 16,604,740 | $305M | Added 7.97% |
| BlackRock | 8,551,488 | $157M | Added 9.19% |
| Vanguard | 8,099,110 | $149M | Added 24.7% |
| Bellevue Group | 6,731,909 | $124M | Added 0.09% |
| Paradigm Biocapital Advisors | 6,723,788 | $124M | Added 113.53% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is VRDN?
Viridian Therapeutics, Inc. Common Stock (VRDN) is listed on Nasdaq, where it has traded since June 18, 2014.
Who are the largest institutional holders of VRDN?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of VRDN were FMR, BlackRock and Vanguard.
How many institutions own VRDN?
207 institutions reported a position in VRDN for the quarter ended June 30, 2026, worth $2.5 billion in total.
Did institutions buy or sell VRDN last quarter?
Of the 5 largest reported holders, all 5 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for VRDN.
Every reported institutional holder, plus insider and congressional trades in VRDN, on SentiSense.